145 related articles for article (PubMed ID: 38306518)
1. Evaluation of the correlation of neutrophil/lymphocyte ratio with prognostic classification systems in papillary thyroid carcinoma patients.
Yildiz EO; Işcen K; Kaya F; Güney OA; Ulukent SC
Medicine (Baltimore); 2024 Feb; 103(5):e37210. PubMed ID: 38306518
[TBL] [Abstract][Full Text] [Related]
2. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?
Lang BH; Ng CP; Au KB; Wong KP; Wong KK; Wan KY
World J Surg; 2014 Oct; 38(10):2605-12. PubMed ID: 24809487
[TBL] [Abstract][Full Text] [Related]
3. May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders?
Kocer D; Karakukcu C; Karaman H; Gokay F; Bayram F
Asian Pac J Cancer Prev; 2015; 16(9):3875-9. PubMed ID: 25987053
[TBL] [Abstract][Full Text] [Related]
4. Delta Neutrophil Index and Neutrophil-to-Lymphocyte Ratio in the Differentiation of Thyroid Malignancy and Nodular Goiter.
Bozan MB; Yazar FM; Kale İT; Yüzbaşıoğlu MF; Boran ÖF; Azak Bozan A
World J Surg; 2021 Feb; 45(2):507-514. PubMed ID: 33067685
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-Lymphocyte Ratio Is Associated With the Proportion of Poorly Differentiated Components in Papillary Thyroid Carcinoma.
Oba T; Maeno K; Kiyosawa N; Morikawa H; Amitani M; Chino T; Shimizu T; Ono M; Ito T; Kanai T; Uehara T; Ito KI
J Surg Res; 2023 Jul; 287():47-54. PubMed ID: 36868123
[TBL] [Abstract][Full Text] [Related]
6. Comparison of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with thyroiditis and papillary tumors.
Ari A; Gunver F
J Int Med Res; 2019 May; 47(5):2077-2083. PubMed ID: 30909773
[TBL] [Abstract][Full Text] [Related]
7. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
[TBL] [Abstract][Full Text] [Related]
8. Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer.
Gong W; Yang S; Yang X; Guo F
Clinics (Sao Paulo); 2016 Jul; 71(6):311-4. PubMed ID: 27438563
[TBL] [Abstract][Full Text] [Related]
9. Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy?
Lin YS; Wu HY; Yu MC; Hsu CC; Chao TC
Medicine (Baltimore); 2016 Jul; 95(28):e4194. PubMed ID: 27428220
[TBL] [Abstract][Full Text] [Related]
10. Optimal cutoff values of primary tumour size to better predict long-term outcomes in patients with papillary thyroid carcinoma undergoing total thyroidectomy: A preliminary study using restricted cubic spline analysis.
Jang SW; Park JH; Kwon HJ; Yoon JH
Clin Endocrinol (Oxf); 2022 Jun; 96(6):888-895. PubMed ID: 34908183
[TBL] [Abstract][Full Text] [Related]
11. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas.
Kim JY; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC; Ha WS; Choi SK; Jung EJ
Endocrine; 2014 Aug; 46(3):526-31. PubMed ID: 24272600
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
13. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
14. Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer.
Yaylaci S; Tosun O; Sahin O; Genc AB; Aydin E; Demiral G; Karahalil F; Olt S; Ergenc H; Varim C
Asian Pac J Cancer Prev; 2016; 17(4):2321-3. PubMed ID: 27221938
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer.
Ozmen S; Timur O; Calik I; Altinkaynak K; Simsek E; Gozcu H; Arslan A; Carlioglu A
Endocr Regul; 2017 Jul; 51(3):131-136. PubMed ID: 28858848
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil to Lymphocyte Ratio is Useful in Differentiation of Malign and Benign Thyroid Nodules.
Sit M; Aktas G; Erkol H; Yaman S; Keyif F; Savli H
P R Health Sci J; 2019 Mar; 38(1):60-63. PubMed ID: 30924917
[TBL] [Abstract][Full Text] [Related]
17. The Neutrophil-to-Lymphocyte Ratio Correlates with Age in Patients with Papillary Thyroid Carcinoma.
Liu J; Du J; Fan J; Liu K; Zhang B; Wang S; Wang W; Wang Z; Cai Y; Li C; Yu T; Zhu G; Chen J; Li C
ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):109-16. PubMed ID: 25896501
[TBL] [Abstract][Full Text] [Related]
18. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
19. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
[TBL] [Abstract][Full Text] [Related]
20. Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma.
Jiang K; Lei J; Chen W; Gong Y; Luo H; Li Z; Gong R; Zhu J
Medicine (Baltimore); 2016 Oct; 95(40):e5079. PubMed ID: 27749581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
